Joel H. Schwartz

1.1k total citations
21 papers, 836 citations indexed

About

Joel H. Schwartz is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Joel H. Schwartz has authored 21 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Joel H. Schwartz's work include Lung Cancer Research Studies (2 papers), Adipose Tissue and Metabolism (2 papers) and Drug-Induced Ocular Toxicity (2 papers). Joel H. Schwartz is often cited by papers focused on Lung Cancer Research Studies (2 papers), Adipose Tissue and Metabolism (2 papers) and Drug-Induced Ocular Toxicity (2 papers). Joel H. Schwartz collaborates with scholars based in United States and India. Joel H. Schwartz's co-authors include Steven C. Borkan, Lewis Landsberg, James B. Young, Max H. Cohen, Edward L. Felix, Bruce R. Bistrian, G. P. Canellos, Susan N. Rosenthal, Michael J. Hassett and Suzana Brozović and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Joel H. Schwartz

21 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel H. Schwartz United States 14 205 205 159 134 97 21 836
J B Elder United Kingdom 17 451 2.2× 333 1.6× 98 0.6× 166 1.2× 208 2.1× 41 1.1k
Olivera Marković Serbia 16 159 0.8× 221 1.1× 112 0.7× 183 1.4× 82 0.8× 90 1.1k
Farhad Navab United States 15 230 1.1× 117 0.6× 108 0.7× 88 0.7× 134 1.4× 49 679
Kalyane Bach‐Ngohou France 18 205 1.0× 209 1.0× 58 0.4× 165 1.2× 83 0.9× 49 946
Giuseppe Fanciulli Italy 21 281 1.4× 355 1.7× 118 0.7× 261 1.9× 157 1.6× 82 1.4k
Jeannie Yip United Kingdom 11 230 1.1× 574 2.8× 191 1.2× 39 0.3× 37 0.4× 12 1.3k
P. C. Ganguli United Kingdom 17 431 2.1× 235 1.1× 82 0.5× 87 0.6× 214 2.2× 31 1.0k
P. A. Bastenie Belgium 20 213 1.0× 179 0.9× 144 0.9× 44 0.3× 28 0.3× 66 1.3k
Alexander Fich Israel 20 529 2.6× 260 1.3× 93 0.6× 169 1.3× 307 3.2× 82 1.4k
A P Savage United Kingdom 16 455 2.2× 227 1.1× 229 1.4× 271 2.0× 189 1.9× 27 1.2k

Countries citing papers authored by Joel H. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Joel H. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel H. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel H. Schwartz more than expected).

Fields of papers citing papers by Joel H. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel H. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel H. Schwartz. The network helps show where Joel H. Schwartz may publish in the future.

Co-authorship network of co-authors of Joel H. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Joel H. Schwartz. A scholar is included among the top collaborators of Joel H. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel H. Schwartz. Joel H. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Niedzwiecki, Donna, Monica M. Bertagnolli, Robert S. Warren, et al.. (2011). Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581. Journal of Clinical Oncology. 29(23). 3146–3152. 56 indexed citations
3.
Hassett, Michael J., Sowmya R. Rao, Suzana Brozović, et al.. (2011). Chemotherapy-Related Hospitalization Among Community Cancer Center Patients. The Oncologist. 16(3). 378–387. 61 indexed citations
4.
Polite, Blasé N., Constance Cirrincione, Gini F. Fleming, et al.. (2008). Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B. Journal of Clinical Oncology. 26(16). 2659–2665. 27 indexed citations
5.
MacKay, Donald G., et al.. (2005). Relations between emotion, illusory word perception, and orthographic repetition blindness: Tests of binding theory. The Quarterly Journal of Experimental Psychology Section A. 58(8). 1514–1533. 15 indexed citations
6.
Schwartz, Joel H., et al.. (1997). Mechanisms of host wasting induced by administration of cytokines in rats. American Journal of Physiology-Endocrinology and Metabolism. 272(3). E333–E339. 73 indexed citations
7.
Schwartz, Joel H., et al.. (1996). Metabolic changes in rats during a continuous infusion of recombinant interleukin-1. American Journal of Physiology-Endocrinology and Metabolism. 270(2). E305–E312. 32 indexed citations
8.
Borkan, Steven C., et al.. (1996). Hepatic alpha 2 mu-globulin: a potential metabolic role in the rat proximal tubule. American Journal of Physiology-Renal Physiology. 271(3). F527–F538. 4 indexed citations
9.
Schwartz, Joel H., et al.. (1992). Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells. American Journal of Physiology-Renal Physiology. 262(6). F957–F964. 21 indexed citations
10.
Schwartz, Joel H., et al.. (1991). Transient ischemia or heat stress induces a cytoprotectant protein in rat kidney. American Journal of Physiology-Renal Physiology. 260(4). F479–F485. 115 indexed citations
11.
Borkan, Steven C. & Joel H. Schwartz. (1989). Role of oxygen free radical species in in vitro models of proximal tubular ischemia. American Journal of Physiology-Renal Physiology. 257(1). F114–F125. 38 indexed citations
12.
Griffin, Thomas W., Andrew I. Cederbaum, Won K. Tak, et al.. (1987). Treatment of advanced ovarian cancer with sequential combination chemotherapy. Cancer. 60(9). 2150–2155. 10 indexed citations
13.
Schwartz, Joel H., et al.. (1983). Characteristics of NH4+ and NH3 transport across the isolated turtle urinary bladder. American Journal of Physiology-Renal Physiology. 245(2). F210–F216. 11 indexed citations
14.
Butkus, Donald E. & Joel H. Schwartz. (1982). Modulation of vasopressin action by reducing agents in Bufo marinus. American Journal of Physiology-Cell Physiology. 243(1). C52–C61. 3 indexed citations
15.
Schwartz, Joel H. & Philip S. Schein. (1978). Fanconi syndrome associated with cephalothin and gentamicin therapy. Cancer. 41(2). 769–772. 18 indexed citations
16.
Schwartz, Joel H., et al.. (1978). Inhibition of toad urinary bladder sodium transport by carbamylcholine: possible role of cyclic GMP. American Journal of Physiology-Renal Physiology. 235(6). F586–F591. 8 indexed citations
17.
Rosenthal, Susan N., Joel H. Schwartz, & G. P. Canellos. (1977). Basophilic Chronic Granulocytic Leukaemia with Hyperhistaminaemia. British Journal of Haematology. 36(3). 367–372. 43 indexed citations
18.
Felix, Edward L., et al.. (1976). Adult intussusception. The American Journal of Surgery. 131(6). 758–761. 149 indexed citations
19.
Schwartz, Joel H., George P. Canellos, Robert C. Young, & Vincent T. DeVita. (1975). Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. The American Journal of Medicine. 59(6). 819–828. 29 indexed citations
20.
Schwartz, Joel H., et al.. (1960). Connective Tissue II. Effect of Age and Sex upon Lipid Composition of Tissues of Rat.. Experimental Biology and Medicine. 103(4). 666–669. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J B Elder Breakdown of academic impact, for papers by Olivera Marković Breakdown of academic impact, for papers by Farhad Navab Breakdown of academic impact, for papers by Kalyane Bach‐Ngohou Breakdown of academic impact, for papers by Giuseppe Fanciulli Breakdown of academic impact, for papers by Jeannie Yip Breakdown of academic impact, for papers by P. C. Ganguli Breakdown of academic impact, for papers by P. A. Bastenie Breakdown of academic impact, for papers by Alexander Fich Breakdown of academic impact, for papers by A P Savage
Rankless by CCL
2026